Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 155c
Tweet
Share
E-mailGet Alerts ATHA Hot Sheet
Join SI Premium – FREE
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($1.68), $1.55 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
- Gray Media prices $750 million in senior secured notes due 2034
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
